FDA.reportPublic FDA data

ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters

RxCUI
1487528
RxNorm name
ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
Display name
ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
Full name
ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Anoro ElliptaUMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATEGlaxoSmithKline LLC2dbd0671-c565-40c5-bf0f-e324db26799c2023-06-02Warnings, Adverse reactionsExact identifier
rxcui: 1487528

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2dbd0671-c565-40c5-bf0f-e324db26799cANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters [PSN] · 30 ACTUAT umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Anoro] [SBD] · Anoro Ellipta (umeclidinium 62.5 MCG / vilanterol 25 MCG) per ACTUAT Dry Powder Inhaler, 30 ACTUAT [SY]329These highlights do not include all the information needed to use ANORO ELLIPTA safely and effectively. See full prescribing information for ANORO ELLIPTA. ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder), for oral inhalation use Initial U.S. Approval: 201320230602